APIs
Pharmaceutical Intermediates
- By Chemical Groups
  - Acids
  - Aldehydes
  - Amides
  - Amidines
  - Amines
  - Azetidines
  - Benzofurans
  - Benzoimidazoles
  - Benzothiophenes
  - Benzotriazoles
  - Biphenyls
  - Boronic Acids
  - Chiral Compounds
  - Chromanes and Chromenes
  - Deuterium
  - Esters
  - Furans
  - Guanidines
  - Halides
  - Homopiperazines
  - Homopiperidines
  - Imidazoles
  - Imidazopyridines
  - Indazoles
  - Indoles and Isoindoles
  - Isocynides
  - Isoquinolines
  - Isoxazoles
  - Ketones
  - Morpholines
  - Naphthalenes
  - Nitriles
  - Oxazoles
  - Phenols
  - Piperazines
  - Piperidines
  - Pyrazoles
  - Pyridazines
  - Pyridines
  - Pyrimidines
  - Pyrroles
  - Pyrrolidines
  - Quinazolines
  - Quinolines
  - Spiro Compounds
  - Tetrazoles
  - Thiazoles
  - Thiophenes
  - Triazoles
- By Disease
Pharmaceutical Excipients
- Common Pharmaceutical Excipients
- Featured Excipient Products
Raw Materials (For APIs Production)
API Processing Chemicals
Recommended Products
- Active Pharmaceutical Ingredients

Antimigraine Agents

Catalog Number	Product Name	CAS No.	Inquiry
PI1289023671	Rimegepant	1289023-67-1	Inquiry
PI1374024482	Rimegepant Sulfate	1374024-48-2	Inquiry
PI1374248777	Ubrogepant	1374248-77-7	Inquiry
PI1374248813	Atogepant	1374248-81-3	Inquiry
PI177834923	Eletriptan HBr	177834-92-3	Inquiry
PI6190392	Dihydroergotamine Mesylate	6190-39-2	Inquiry

Introduction to Migraine

Migraine is a prevalent and disabling neurological condition characterized by recurrent episodes of moderate to severe headache, often accompanied by nausea, vomiting, and sensitivity to light and sound. Migraine affects over one billion people worldwide and is ranked among the top causes of years lived with disability. It is a complex condition with both genetic and environmental influences. While migraines can vary in severity and frequency, the most common forms include:

Episodic migraine: Less than 15 headache days per month
Chronic migraine: 15 or more headache days per month, with at least 8 days being migrainous

The need for effective, targeted therapies is urgent, particularly those that can reduce both the frequency and intensity of attacks with minimal side effects. APIs that target migraine pathways are essential in developing such therapies.

Classification of Antimigraine Agents

Antimigraine agents are broadly divided into two categories: acute treatments and preventive treatments. Each class utilizes different APIs to address various aspects of the disease.

Acute Antimigraine Agents

These are used to treat migraine attacks after they begin. Common classes of acute antimigraine APIs include:

Triptans: Sumatriptan, Rizatriptan, Zolmitriptan
Ergot Alkaloids: Ergotamine, Dihydroergotamine
Ditans: Lasmiditan
Gepants: Ubrogepant, Rimegepant

Preventive Antimigraine Agents

These are taken regularly to reduce the frequency and severity of migraine attacks. Common APIs include:

Beta-blockers: Propranolol, Metoprolol
Anticonvulsants: Topiramate, Valproate
Calcium Channel Blockers: Verapamil
CGRP Monoclonal Antibodies: Erenumab, Fremanezumab (biologics often studied in peptide form for research)

Mechanisms of Action of Key Antimigraine APIs

Class	Main Mechanism	Description
Triptans	Serotonin (5-HT1B/1D) receptor agonists	Triptans bind to 5-HT1B and 5-HT1D receptors in the brain. These receptors are found on blood vessels and nerve endings in the trigeminal system, a critical pathway in migraine pathophysiology.
Gepants	CGRP receptor antagonists	Gepants block the calcitonin gene-related peptide (CGRP) receptor, which plays a central role in migraine development.
Ditans	5-HT1F receptor agonists	Ditans selectively activate 5-HT1F receptors, which are involved in suppressing pain transmission without causing vasoconstriction.
Beta-Blockers		Used preventively, beta-blockers are thought to stabilize vascular tone and reduce cortical excitability.
CGRP Monoclonal Antibodies		These biologics either neutralize circulating CGRP or block its receptor, offering long-term preventive effects against migraines.
Calcium Channel Blockers		While more commonly used in cluster headaches, some calcium channel blockers are used off-label for migraine prevention.

Partner with Us

At our company, we offer a comprehensive range of APIs used in the development and study of antimigraine therapies. Each product is manufactured to high standards and is accompanied by detailed documentation. Whether your project involves high-throughput screening, mechanism-of-action studies, or preclinical development, we offer:

Flexible order quantities (from milligrams to kilograms)
Technical support from experienced scientists
Global shipping with safe and compliant logistics

We welcome collaborations with academic and industrial partners seeking tailored solutions in the field of migraine research.

Online Inquiry

Please kindly note that our services are for research use only.

Antimigraine Agents

Introduction to Migraine

Classification of Antimigraine Agents

Mechanisms of Action of Key Antimigraine APIs

Partner with Us

Get in Touch